Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
A ten-year comparison of Aristocrats ETFs highlights performance patterns, dividend consistency, and growth trajectory to aid selection.
27,136 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Catena Labs, led by Circle cofounder Sean Neville, closes a $30 million Series A to expand AI-driven payments tools a...
Sara Holtz, chief marketing officer at Optimal Blue, outlines a leadership playbook that uses AI to sharpen decision-...
A stubborn drought threatens the nation’s largest oil export hub in Corpus Christi, forcing lawn bans and possible em...
Tech stocks lead gains as the Nasdaq Composite climbs to fresh highs, fueled by AI optimism and strong earnings momen...
Girls Who Code CEO Tarika Barrett says 70% of teen girls want cybersecurity careers, but a weak pipeline threatens a ...
Solana has faced headwinds, but many investors wonder if solana about have biggest could finally arrive in the second...
Ethereum faces another wave of selling pressure as macro tensions, on-chain signals, and sentiment converge. This gui...
NVIDIA stock is approaching its 52-week high as AI-driven demand sustains a rally across the tech sector. Analysts we...
Bitcoin briefly pushed into the mid-$60,000s before pulling back, while a top analyst cautions that the bounce may no...
Federal authorities executed a search warrant at a Southern California aerospace site after a chemical tank overheate...
Investors eye a potential SpaceX IPO as a catalyst for sweeping changes in billionaire wealth dynamics. If priced hig...